Democratic Republic of Congo vs Madagascar: Treatment coverage for lymphatic filariasis
Democratic Republic of Congo
80.5%
in 2024
Madagascar
81.5%
in 2024
Democratic Republic of Congo rank
16th
Madagascar rank
15th
Treatment coverage for lymphatic filariasis over time
- Democratic Republic of Congo
- Madagascar
How they compare
Madagascar currently reports 81.5% against 80.5% in Democratic Republic of Congo, a difference of 1.0%.
The two have swapped places 4 times across 10 shared years of data; in 2014 it was Madagascar ahead.
Democratic Republic of Congo ranks 16th and Madagascar ranks 15th of 66 countries.
Democratic Republic of Congo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.8% | 30.7% | 18.1% | Democratic Republic of Congo |
| 2020s | 66.0% | 41.1% | 24.9% | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Democratic Republic of Congo or Madagascar?
- Madagascar, at 81.5% against 80.5% in Democratic Republic of Congo as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Democratic Republic of Congo and Madagascar?
- 1.0%, with Madagascar ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Madagascar?
- 10 years are reported by both, from 2014 to 2024.
- How do Democratic Republic of Congo and Madagascar rank globally for treatment coverage for lymphatic filariasis?
- Democratic Republic of Congo ranks 16th and Madagascar ranks 15th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.